BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CASL - Canadian Association for the Study of the Liver
X-ORIGINAL-URL:https://hepatology.ca
X-WR-CALDESC:Events for CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240509T080000
DTEND;TZID=UTC:20240509T170000
DTSTAMP:20260416T230733
CREATED:20240428T160326Z
LAST-MODIFIED:20240508T194153Z
UID:3553-1715241600-1715274000@hepatology.ca
SUMMARY:Canadian Viral Hepatitis Elimination Day
DESCRIPTION:On Thursday\, May 9\, 2024\, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada\, CanHepC\, CanHepB\, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa. \n#CanHepDay24  #HepCantWait \nThank you to our many members and allies who are helping amplify our call for the federal government\, as well as each province and territory\, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. \nFIVE FEDERAL ASKS \nIn 2016\, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories\, there are five key things the federal government can do now. \n1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.\nAn updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan. \n2. Testing: Update hepatitis C screening guidelines to be evidence-based\, develop evidence-based screening guidelines for hepatitis B\, and start offering free\, voluntary STBBI testing and linkage to care for all immigrants and newcomers.\nCanada’s hepatitis C screening guidelines recommend only screening people with certain risk factors\, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all\, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis. \n3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.\nHepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment\, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.\n​\n4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.\nHepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12\, which have a vaccination rate of ~70%\, missing the 90% WHO target. \n5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.\nIn order to measure our progress in viral hepatitis elimination\, we need reliable\, fulsome data about how many people are affected. \n\n\n\n\n\n\nSocial Media Graphics for Sharing\n\n\n\n\n\n\nThese graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.\n\n \n\n\nClick on the image to save it\n \n\nClick on the image to save it
URL:https://hepatology.ca/event/canadian-viral-hepatitis-elimination-day/
LOCATION:Ottawa\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240503
DTEND;VALUE=DATE:20240505
DTSTAMP:20260416T230733
CREATED:20240218T204323Z
LAST-MODIFIED:20240218T204323Z
UID:3488-1714694400-1714867199@hepatology.ca
SUMMARY:Innovations in SLD Think-Tank 2024
DESCRIPTION:This 2-day program will provide an interactive platform for endocrinologists\, gastroenterologist hepatologists\, primary care physicians\, and associated health care professionals (PAs\, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise. \n \nThe new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations: \n\nBridging the Diagnostics Gap\nPrevention is the ‘Cure’ Hidden in Plain Sight\nThe Future of Treatments Now\nMaking Ready Our World Unready\nTargeting Investments for Social and Economic Returns\nthe Role of Social Media in MASLD Education\nOpen Science Session on MASLD\n\nEach of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members\, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics. \nRegister for SLD Think-Tank 2024 \nIn addition\, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions. \nAbstract Deadline: Friday\, 1 March 2024 at 23:59 CET \nAbstract Submission Link: https://virology.eventsair.com/sld2024/abstracts \n \n 
URL:https://hepatology.ca/event/innovations-in-sld-think-tank-2024/
CATEGORIES:In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20240419T100000
DTEND;TZID=Europe/Helsinki:20240419T113000
DTSTAMP:20260416T230733
CREATED:20240328T174114Z
LAST-MODIFIED:20240328T174352Z
UID:3533-1713520800-1713526200@hepatology.ca
SUMMARY:World Liver Awareness Day Webinar
DESCRIPTION:SOLDA is proud to present World Liver Awareness Day Webinar\, a 90-minute webinar focusing on challenges and solutions for liver disease in Africa. \nThe 90-minute program takes place on World Liver Day – 19 April 2024 – and showcases presentations from leading experts from the five African regions. The scientific program focuses on regionally prevalent and emerging liver diseases and special emphasis will be placed on ensuring the voices of those with lived experiences will be heard. \n \n10:00 AM CAT / SAST\nWHA – Patient Advocacy Group | The “Lost Voice” of the Patient Community\nDanjuma K. Adda\, MPH\, FIMS\, Dip-IMS\, World Hepatitis Alliance (WHA)\, Nigeria\n \n10:10 AM CAT / SAST\nEastern Africa | Viral Hepatitis (Delivery of Care Models)\nMercy Nyakowa\, MD National AIDS and STI Control Program (NASCOP)\, Ministry of Health\, Kenya\nHailemichael Desalegn Mekonnen\, MD\, PhD\, St. Paul’s Hospital Millennium Medical College\, Ethiopia\nPonsiano Ocama\, MBChB\, MMed\, PhD\, FCP(ECSA)\, Makerere University College of Health Sciences\, Uganda \n10:20 AM CAT\nWestern Africa | Role of Prolifica in Viral Hepatitis (Implementation & Research)\nGibril Ndow\, MD\, PhD\, Unit The Gambia at LSHTM\, The Gambia\nAlice Nanelin Guingané\, MD\, MPH\, Bogodogo University Hospital Center / University of Montpellier\, Burkina Faso / France \n10:30 AM CAT / SAST\nCentral Africa | Vertical Transmission\nChristian Tzeuton\, MD\, Douala Medical School / Société Camerounaise de Gastro-Entérologie\, Cameroon \n10:40 AM CAT / SAST\nSouthern Africa | Alcohol & Toxins\nWendy Spearman\, MBChB\, FCP\, FRCP\, MMed\, PhD\, University of Cape Town\, South Africa\nMark Sonderup\, B Pharm\, MBChB\, FCP(SA)\, MMed\, University of Cape Town\, South Africa\nSeadimo Gasennelwe-Gabakgore\, MD\, MPH\, Ministry of Health and Wellness\, Botswana \n10:50 AM CAT / SAST\nNorthern Africa | HCC\nManal Hamdy El-Sayed\, MD\, PhD\, Ain Shams University\, Egypt\nAshraf Omar\, MD\, MSc\, Cairo University\, Egypt\nNabil Debzi\, MD\, Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers\, Algeria \n11:00 AM CAT / SAST\nQ&A \n11:30 AM CAT / SAST\nClosure of Webinar \n 
URL:https://hepatology.ca/event/world-liver-awareness-day-webinar/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240411
DTEND;VALUE=DATE:20240412
DTSTAMP:20260416T230733
CREATED:20240218T203052Z
LAST-MODIFIED:20240318T174948Z
UID:3481-1712793600-1712879999@hepatology.ca
SUMMARY:Obesity Update Congress
DESCRIPTION:The inaugural Obesity Update (OU) congress is taking place on Thursday\, April 11\, 2024\, at the InterContinental Toronto Centre. Additional information about the congress can be found on the website at www.obesityupdate.ca.
URL:https://hepatology.ca/event/obesity-update-congress/
LOCATION:InterContinental Toronto Centre\, 225 Front Street West\, Toronto\, Ontario\, M5V 2X3\, Canada
CATEGORIES:In-Person,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240315
DTEND;VALUE=DATE:20240501
DTSTAMP:20260416T230733
CREATED:20240315T144325Z
LAST-MODIFIED:20240508T194211Z
UID:3515-1710460800-1714521599@hepatology.ca
SUMMARY:Online Opioid Self-Assessment Program (SAP)
DESCRIPTION:Improve your opioid prescribing skills with the Online Opioid SAP accredited by both the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada. Engage with the latest Canadian Opioid Guideline through interactive case studies and personalized feedback. Funded by Health Canada and CGPA\, this not-for-profit program is your gateway to evidence-based opioid management. \nThis course is accredited as Section 3 for specialists (3 credits/hour) and Mainpro+ for Family Physicians (1 credit/hour). \nThe Online Opioid SAP is easily accessible\, highly interactive\, and it uses assessment as a technique for knowledge exchange and guideline implementation. To facilitate active learning\, various styles are employed\, including videos\, case presentations\, and an assortment of question types to keep you engaged and apply it in practice. \nSecure\, confidential\, and always seeking your feedback to improve healthcare practices. Join the Online Opioid SAP  at https://opioidassessment.ca/ and elevate your clinical expertise today. \n \n 
URL:https://hepatology.ca/event/online-opioid-self-assessment-program/
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240221T120000
DTEND;TZID=America/Toronto:20240221T120000
DTSTAMP:20260416T230733
CREATED:20240218T201825Z
LAST-MODIFIED:20240218T202117Z
UID:3477-1708516800-1708516800@hepatology.ca
SUMMARY:Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
DESCRIPTION:The Canadian Society of Palliative Care Physicians has partnered with the Pulmonary Hypertension Association of Canada to offer the webinar\, Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension\, on Feb 21st.  \nPalliative Care ECHO Project to offer targeted webinars to all physicians who treat patients with life-limiting illness. These sessions are accredited\, free and open to everyone.  \n \n  \nQuality of Life Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension \nWEDNESDAY\, February 21\, 2024TIME: 9 AM PT / 10 AM MT / 3 PM CT / 4 PM ET / 5 PM ATL / 5:30 PM NL \nHosted by the Canadian Society of Palliative Care Physicians (CSPCP) and Pulmonary Hypertension Association of Canada (PHA Canada) \nPresenters:    \nDr. David Christiansen\, MD FRCPC \nAssociate Professor and Co-Section Head\, Section of Respirology\, \nUniversity of Manitoba \nDr. Kirsten Wentlandt\, MD\, CCFP(PC)\, FRCPC\, PhD\, MHSc \nW. Gifford-Jones Professor in Pain Control and Palliative Care\, \nHead of the Division of Palliative Care\, University of Toronto \nTarget Audience: Physicians from across Canada \nDescription:Explore palliative care strategies for individuals with pulmonary hypertension (PH). We’ll delve into the disease course\, prognosis\, and impact on quality of life for patients with PH. Additionally\, we’ll examine the opportunities and challenges in providing palliative care to individuals facing this condition\, highlighting unique aspects as it relates to palliative care interventions. \nIn this session\, we will: \n\nreview disease course\, quality of life and prognosis of pulmonary hypertension (PH).\nreview opportunities and challenges in providing palliative care to patients with PH.\ndiscuss unique aspects of PH as it pertains to palliative care interventions.\n\n  \nECHO sessions are free to attend and open to any person with an interest in the topic; however\, the subject material is designed for physician audiences. \nAt the beginning of this session\, the speaker(s) will present a case\, which will be followed by a moderated and interactive discussion among participants. \nThe CSPCP Palliative Care Echo Sessions is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nCFPC members may claim 1 Mainpro+ Non-certified Group Learning credit
URL:https://hepatology.ca/event/quality-of-lift-matters-palliative-care-strategies/
LOCATION:Online
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR